NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mega-Dose vitamin c joins fight against lung cancer
Disease control OngoingThis study is testing whether adding very high doses of vitamin C (given through an IV) to standard chemotherapy and radiation treatment helps people with non-small cell lung cancer. All 43 participants will receive the vitamin C infusion along with their usual cancer therapy. Re…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Joseph J. Cullen, MD, FACS • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Last-Hope drug access for advanced lung cancer patients
Disease control NO_LONGER_AVAILABLEThis was a special access program for the drug capmatinib. It was designed for patients with a specific, advanced form of non-small cell lung cancer who had no other treatment options and could not join a standard clinical trial. The program provided the drug outside of a trial s…
Matched conditions: NONSMALL CELL LUNG CANCER
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for tough cancers: experimental combo targets key mutation
Disease control OngoingThis study is testing new drug combinations for people with advanced solid tumors that have a specific genetic change called KRAS G12C. It focuses on patients with non-small cell lung cancer or colorectal cancer who have already tried standard treatments. The main goals are to fi…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Research probes survival gap for native americans on cancer immunotherapy
Knowledge-focused OngoingThis study looks back at medical records to understand how well immunotherapy cancer drugs work for American Indian patients compared to White patients. Researchers will analyze survival times, side effects, and cancer-related deaths in 72 patients who were treated between 2015 a…
Matched conditions: NONSMALL CELL LUNG CANCER
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC